Investing.com - NeoGenomics (NASDAQ:NEO) reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
NeoGenomics announced earnings per share of $-0.14 on revenue of $128.78M. Analysts polled by Investing.com anticipated EPS of $-0.20 on revenue of $122.41M.
NeoGenomics shares are down 23% from the beginning of the year, still down 83.96% from its 52 week high of $44.26 set on November 10, 2021.
NeoGenomics follows other major Healthcare sector earnings this month
NeoGenomics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar